924 related articles for article (PubMed ID: 17683489)
21. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
22. Decreased expressions of hepsin in human hepatocellular carcinomas.
Chen CH; Su KY; Tao MH; Lin SW; Su YH; Tsai YC; Cheng KC; Jeng YM; Sheu JC
Liver Int; 2006 Sep; 26(7):774-80. PubMed ID: 16911458
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
24. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
[TBL] [Abstract][Full Text] [Related]
27. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
[TBL] [Abstract][Full Text] [Related]
28. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
30. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of suppressive role of RASSF1A gene at 3p21.3 in lung cancer cell line A549].
Zhang S; Shao K; Zhang CY; Zhou F; Wang W; Xiong MH; He J
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):908-11. PubMed ID: 16029530
[TBL] [Abstract][Full Text] [Related]
32. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
Kremer-Tal S; Reeves HL; Narla G; Thung SN; Schwartz M; Difeo A; Katz A; Bruix J; Bioulac-Sage P; Martignetti JA; Friedman SL
Hepatology; 2004 Nov; 40(5):1047-52. PubMed ID: 15486921
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
[TBL] [Abstract][Full Text] [Related]
35. The human LIS1 is downregulated in hepatocellular carcinoma and plays a tumor suppressor function.
Xing Z; Tang X; Gao Y; Da L; Song H; Wang S; Tiollais P; Li T; Zhao M
Biochem Biophys Res Commun; 2011 Jun; 409(2):193-9. PubMed ID: 21569763
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
Wang H; Jiang H; Zhou M; Xu Z; Liu S; Shi B; Yao X; Yao M; Gu J; Li Z
Cancer Lett; 2009 Jun; 279(1):30-8. PubMed ID: 19217205
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
[TBL] [Abstract][Full Text] [Related]
39. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC
J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269
[TBL] [Abstract][Full Text] [Related]
40. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]